CD274 and cancer: In recent decades, cancer immunotherapies like chimeric antigen receptor-engineered T cell (CAR-T), checkpoint blockade of PD-1/PD-L1, etc., are emerging in an endless stream which arrests the attention of physicians, patients and researchers from all over the world for their different, genius and extraordinary efficiency on cancer treatment compared with traditional chemotherapy and radiotherapy.